{
"ProductData": {
"ID": "3.7.9.16.1.2",
"ProductType": "Others",
"BrandName": "MAB<H-S-Amy>M-Tu66C7 IgG",
"ProductNameAddition": "lyophilizate",
"RegulatoryDisclaimer1": "For further processing only.",
"DisclaimerGroup1": "",
"RegulatoryDisclaimer2": null,
"DisclaimerGroup2": null,
"RegulatoryDisclaimer3": null,
"SampleType": [
],
"LicenseDisclaimers": [
],
"RelatedLinks": "",
"Clone": "",
"ControlTissue": [
""
],
"ISOtypes": "",
"Species": [
""
],
"StainLocalization": [
""
],
"ProductNameGlobal": "MAB H-S-Amy M-Tu66C7 IgG"
},
"ProductImageDetails": {
"ImagePath": "https://pim-media.roche.com/Images/CB_IMAGE_.png",
"ImageType": "Image main"
},
"Product2Taxonomy": {
"Product2TaxonomyReferences": [
{
"StructureSystemIdentifier": "OWP_Product_Types",
"StructureSystemName": "Product Types",
"NodeID": "70-058-00",
"StructureNodeStatus": "valid",
"NodeName": "Antibodies"
},
{
"StructureSystemIdentifier": "OWP_Organization",
"StructureSystemName": "Organization",
"NodeID": "01-01-01-07-00",
"StructureNodeStatus": "valid",
"NodeName": "CustomBiotech and LifeScience"
},
{
"StructureSystemIdentifier": "Product_Grouping",
"StructureSystemName": "Product Grouping",
"NodeID": "02-0011",
"StructureNodeStatus": "valid",
"NodeName": "Clinical Chemistry Raw Materials"
},
{
"StructureSystemIdentifier": "Applications",
"StructureSystemName": "Applications",
"NodeID": "06-00-00",
"StructureNodeStatus": "valid",
"NodeName": "Enzyme Testing"
},
{
"StructureSystemIdentifier": "Product_Solutions",
"StructureSystemName": "Product Solutions",
"NodeID": "520",
"StructureNodeStatus": "valid",
"NodeName": "CustomBiotech"
},
{
"StructureSystemIdentifier": "Lab_Type",
"StructureSystemName": "Lab Types",
"NodeID": "180-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "OWP_Techniques",
"StructureSystemName": "Techniques",
"NodeID": "999-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "Disease_Areas",
"StructureSystemName": "Disease Areas",
"NodeID": "99-00-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "Pathogens",
"StructureSystemName": "Pathogens",
"NodeID": "99-00-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "OWP_Family",
"StructureSystemName": "Product Families",
"NodeID": "999",
"StructureNodeStatus": "invalid",
"NodeName": ""
},
{
"StructureSystemIdentifier": "Health_Topics",
"StructureSystemName": "Health Topics",
"NodeID": "99-00-00",
"StructureNodeStatus": "invalid",
"NodeName": ""
}
]
},
"Product2Materials": {
"P2MaterialReferences": [
{
"MaterialNum": "11543601103",
"MaterialDescription": "MAK
M-Tu66C7-IgG(BR)SQ",
"RegisteredProductName": "MABM-Tu66C7 IgG",
"GTIN": "",
"ProductCategoryText": "Reagents, kits",
"OldMaterialNumber": "",
"PackSizePIM360": "custom fill",
"PackSizeDescPIM360": "Not Available",
"MaterialAnnotation": "CustomBiotech product. Please contact your local representative.",
"ReadyForUse": "",
"OrderInformation": "Will be supplied as \"MAK<H-S-Amy>M-Tu66C7-IgG(BR)SQ\". Unit of measure is \"g active ingredient\"."
}
]
},
"Product2Products": {
"Product2ProductReference": [
]
},
"ProductSpec": [
{
"ProductSpecVariant": {
"Chapters": [
{
"Name": "CB - Order Information",
"Value": "Will be supplied as \"MAK<H-S-Amy>M-Tu66C7-IgG(BR)SQ\". Unit of measure is \"g active ingredient\".",
"Language": "en",
"Country": "XG",
"Code": "CB - Order Information"
},
{
"Name": "Applications",
"Value": "The combination of MAB<H-S-Amy>Tu88E8 and MAB<H-S-Amy>Tu66C7 inhibits the human salivary α-amylase ≥97% while maintaining the activity of the pancreatic h-α-amylase.",
"Language": "en",
"Country": "XG",
"Code": "Applications"
},
{
"Name": "Product Description",
"Value": "Immunogen: Human salivary amylase
Spleen donor: Mouse Balb/c
Antibody class: IgG1, kappa
Clone: Tu66C7
Cross reactivity to h-pancreas α-amylase: ≤1 U/gW",
"Language": "en",
"Country": "XG",
"Code": "Product Description"
},
{
"Name": "Positioning",
"Value": "For measurement of acute pancreatitis (pancreatic α-amylase) in human serum and urine selective blocking of salivary α-amylase isoenzyme is achieved in the presence of the pancreatic h-α-amylase.
Qualified for the cobas® platforms.",
"Language": "en",
"Country": "XG",
"Code": "Positioning"
},
{
"Name": "Properties",
"Value": "MAB<H-S-Amy>M-Tu66C7 IgG fraction is purified by chromatography and lyophilized from a solution containing protein (≥20 mg/mL), potassium-phosphate buffer and NaCl. No preservatives are added.",
"Language": "en",
"Country": "XG",
"Code": "Properties"
},
{
"Name": "Specification",
"Value": "Appearance: White lyophilizate
Solubility: Clear colorless solution in NaCl, 0.9% (c=10 mg/mL)
Protein (Biuret): ≥0.7 mg/mg lyophilizate
Purity (HPLC / Mono Q): ≥90 area%
Function testing (synergetic effects at +37°C):
h salivary amylase + MAB : ≤3% amylase activity
h pancreas amylase + MAB <S-AMY>: ≥98% amylase activity
Stability: At -15 to -25°C within specification range for 24 months. Avoid repeated freezing and thawing.",
"Language": "en",
"Country": "XG",
"Code": "Specification"
}
]
}
}
]
}